ARTICLE | Clinical News
Oral Panretin 9-cis-retinoic acid: Phase II Update
July 14, 1997 7:00 AM UTC
Allergan Ligand Retinoid Therapeutics Inc. (ALRI), San Diego, Calif. Product: Oral Panretin 9-cis-retinoic acid Indication: Treat myelodysplastic syndrome (premalignancy of blood) Status: Phase II tes...